YOLFTbeta
Shandong Intco Medical Products Co Ltd

Shandong Intco Medical Products Co Ltd

300677 · SHE · Healthcare / Medical Instruments & Supplies

44.60CNY+1.43 (+3.31%)

Price History

Full chart

Market Stats

Previous Close43.17
Open43.07
Day Range42.85 – 45.32
52-Week Range35.64 – 68.17
Volume7.64M
Market Cap33.37B
P/E (TTM)29.12
Forward P/E0.00
EPS1.75
Dividend Yield0.39%
Beta0.11
50-Day Avg51.02
200-Day Avg48.03

About

Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers disposable gloves, gowns, apparel, face masks, diaper, pad, wipes, non-woven sundries, PE products, and hand hygiene; wheelchair, scooter, rollator, lift, and others; physical therapy hot and cold therapy, sport and outdoor, pet products, patient monitoring, and electrosurgery. It also provides ECG electrode, such as monitoring ECG, stress test and holter, diagnostic ECG, pre-wired neonatal, repositionable, tens, off-set ECG, and defibrillation electrode; grounding pad, electrosurgical pencil, and feminine care. The company was formerly known as Intco Medical Technology Co., Ltd. and changed its name to Intco Medical Technology Co., Ltd. in January 2020. Intco Medical Technology Co., Ltd. was founded in 2009 and is headquartered in Zibo, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Qiong Chen
  • Employees12.94K
  • HeadquartersNo.18, Qingtian Road, Zibo, China, 255414, China
  • Websitehttps://www.intcomedical.com.cn

Leadership

  • Ms. Qiong ChenGM & Director · b. 1982
  • Ms. Feng JieCFO & Secretary · b. 1985
  • Mr. Hai Sheng YuDeputy GM & Non-Independent Director · b. 1976
  • Yufa JiaoHead of Accounting Department

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue713.28M884.71M998.02M1.18B1.75B1.89B2.08B13.84B16.24B6.61B6.92B9.52B9.93B
Growth (%)-+24.03%+12.81%+18.55%+47.96%+8.12%+10.06%+564.29%+17.37%-59.27%+4.61%+37.65%+4.23%
Cost of Revenue607.03M727.45M734.83M893.30M1.32B1.43B1.56B4.29B6.27B5.78B5.98B7.35B7.53B
Gross Profit106.25M157.27M263.19M289.80M434.39M467.26M521.06M9.55B9.97B837.65M942.35M2.18B2.39B
Gross Margin14.90%17.78%26.37%24.50%24.82%24.69%25.02%68.98%61.41%12.67%13.62%22.85%24.12%
Operating Expense78.21M117.53M184.81M189.79M265.95M263.74M318.60M1.18B1.28B130.47M503.36M499.04M1.42B
Operating Income28.04M39.74M78.38M100.01M168.45M203.51M202.45M8.37B8.69B707.18M438.99M1.68B973.99M
Operating Margin3.93%4.49%7.85%8.45%9.62%10.75%9.72%60.48%53.50%10.69%6.34%17.61%9.81%
EBITDA51.23M80.46M115.66M146.26M265.62M265.52M308.96M8.76B8.95B556.79M557.08M1.74B2.57B
EBITDA Margin7.18%9.09%11.59%12.36%15.17%14.03%14.83%63.29%55.11%8.42%8.05%18.27%25.86%
Net Income10.70M31.85M64.22M86.05M145.08M179.34M178.32M7.01B7.43B629.07M383.00M1.47B1.01B
Net Income Margin1.50%3.60%6.43%7.27%8.29%9.48%8.56%50.64%45.75%9.51%5.54%15.39%10.18%
R&D20.47M24.88M28.73M38.15M56.91M62.56M67.60M293.30M365.22M252.32M283.37M398.34M404.38M
R&D as % of Total Revenue2.87%2.81%2.88%3.22%3.25%3.31%3.25%2.12%2.25%3.82%4.10%4.18%4.07%
Interest Expense-13.05M12.06M9.31M15.18M15.78M30.36M24.43M21.11M31.92M135.67M322.22M369.15M
Interest Expense % of Total Revenue-1.47%1.21%0.79%0.87%0.83%1.46%0.18%0.13%0.48%1.96%3.38%3.72%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets704.49M656.54M754.13M1.16B1.66B2.42B2.99B12.93B20.62B21.48B27.08B34.63B40.09B
Total Liabilities556.67M488.16M338.94M628.30M570.73M1.15B1.49B3.49B4.50B5.43B10.78B16.95B21.52B
Total Equity146.12M168.38M415.19M535.45M1.09B1.27B1.48B9.34B15.87B15.81B16.03B17.40B18.25B
Cash52.78M93.74M60.67M104.46M287.36M857.95M614.28M5.01B5.00B5.03B7.22B12.01B5.95B
Total Debt218.94M286.88M153.79M360.08M250.95M816.13M998.20M252.27M255.13M1.55B7.11B12.83B-
Net Debt166.16M193.14M93.11M255.61M-36.41M-41.82M383.92M-4.76B-4.75B-3.49B-110.62M818.99M10.85B

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow74.52M77.28M76.29M80.62M247.48M185.78M329.69M8.59B8.68B1.07B502.41M1.08B1.89B
Investing Cash Flow-94.28M-102.86M-123.62M-212.24M-380.58M-179.94M-791.10M-4.01B-7.73B-1.87B-3.98B-3.87B-
Financing Cash Flow19.43M36.94M37.90M151.12M333.11M259.88M474.20M56.14M-833.25M549.05M3.01B1.42B-
Capital Expenditure68.73M49.52M144.36M215.36M212.22M308.55M536.57M2.89B5.44B1.72B1.44B1.79B2.57B
Free Cash Flow5.79M27.76M-68.07M-136.90M35.26M-122.77M-206.88M5.70B3.24B-649.76M-936.28M-710.37M-689.72M
Dividends Paid10.74M11.86M11.54M14.57M14.83M28.17M29.74M144.16M1.06B412.20M184.92M338.28M422.17M
FCF to OCF7.77%35.92%-89.22%-169.81%14.25%-66.09%-62.75%66.37%37.29%-60.98%-186.36%-65.83%-36.59%
Dividend Paid to FCF185.53%42.73%-16.95%-10.65%42.05%-22.94%-14.38%2.53%32.65%-63.44%-19.75%-47.62%-61.21%

Earnings

Report DateOct 26, 2017Dec 31, 2017Apr 26, 2018Aug 23, 2018Oct 30, 2018Dec 31, 2018Apr 29, 2019Aug 30, 2019Oct 28, 2019Mar 13, 2020Apr 26, 2020Aug 27, 2020Oct 27, 2020Mar 15, 2021Apr 22, 2021Aug 29, 2021Oct 26, 2021Mar 17, 2022Apr 28, 2022Aug 29, 2022Oct 27, 2022Dec 31, 2022Apr 27, 2023Aug 29, 2023Oct 27, 2023Feb 22, 2024Apr 23, 2024Jun 30, 2024Oct 28, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------
EPS Actual0.100.060.040.090.110.100.060.070.090.100.282.717.137.5510.313.091.710.900.130.490.36-0.01-0.010.690.060.080.360.540.161.210.550.570.340.120.021.28
Surprise------------------------------------
TimingPre-market-Pre-marketPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap33.37B
Enterprise Value34.96B
Trailing P/E29.12
Forward P/E0.00
Price / Sales2.80
Price / Book1.72
EPS1.75
Book Value24.46
Revenue (TTM)11.92B
Gross Profit (TTM)3.84B
EBITDA3.23B
Profit Margin9.54%
Operating Margin33.99%
Return on Equity6.50%
Return on Assets3.35%
Shares Outstanding654.75M
Shares Float496.08M
Beta0.11
Dividend Yield0.39%
Dividend Rate0.20
Payout Ratio11.33%

Dividends

20262×
0.10Sep 4, 20260.10Jun 11, 2026
20252×
0.05Sep 30, 20250.10Jun 13, 2025
20242×
0.05Oct 31, 20240.08May 31, 2024
20231×
0.10Jun 7, 2023
20221×
0.75Jun 13, 2022
20211×
1.67Apr 20, 2021
20202×
0.19Oct 12, 20200.06Jun 5, 2020
20191×
0.06Jun 5, 2019
20181×
0.03Apr 27, 2018

Stock Splits

  • Jun 13, 20221.2:1
  • Sep 30, 20211.5:1
  • Oct 12, 20201.5:1
  • Apr 27, 20182:1